Uses of ecologic studies in the assessment of intended treatment effects

Journal of Clinical Epidemiology

Volumn 52, Issue 1, 1999, Pages 7-12

  Wen, Shi Wu ^a   Kramer, Michael S ^b  

^a LAB CENTRE FOR DISEASE CONTROL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Analytic studies; Confounding; Ecological bias; Epidemiologic methods; Outcome assessment; Treatment outcome

Indexed keywords

ARTICLE; DISEASE SEVERITY; ECOLOGY; ENVIRONMENTAL FACTOR; OUTCOMES RESEARCH; PRIORITY JOURNAL; SOCIOECONOMICS; STATISTICAL ANALYSIS;

EID: 0344628714     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00136-X     Document Type: Article

References (32)

1. Richardson S., Stucker I., Hemon D. Comparison of relative risks obtained in ecological and individual studies. Some methodological considerations Int J Epidemiol. 16:1987;111-120.
2. Piantadosi S., Byar D.P., Green S.B. The ecological fallacy. Am J Epidemiol. 127:1988;893-904.
3. Greenland S., Morgenstern H. Ecological bias, confounding, and effect modification. Int J Epidemiol. 18:1989;269-274.
4. Greenland S., Robins J. Invited commentary. Ecologic studies-biases, misconceptions, and counterexamples Am J Epidemiol. 139:1994;747-760.
5. Piantadosi S. Invited commentary. Ecologic biases Am J Epidemiol. 139:1994;761-764.
6. Susser M. The logic in ecological. I. The logic of analysis Am J Public Health. 84:1994;825-829.
7. Schwartz S. The fallacy of the ecological fallacy. The potential misuse of a concept and the consequences Am J Public Health. 84:1994;819-824.
8. Koopman J.S., Longini I.M. The ecological effects of individual exposures and nonlinear disease dynamics in populations. Am J Public Health. 84:1994;836-842.
9. Wynder E.L. Invited commentary. Response to Science article, "Epidemiology faces its limits" Am J Epidemiol. 143:1996;747-749.
10. Wynder E.L., Stellman S.D. The "over-exposed" control group. Am J Epidemiol. 135:1992;459-461.
11. McPherson K. The best and the enemy of the good. Randomised controlled trials, uncertainly, and assessing the role of patient choice in medical decision making J Epidemiol Comm Health. 48:1994;6-15.
12. Feinstein A.R. Current problems and future challenges in RCTs. Circulation. 70:1984;767-774.
13. Kramer M.S., Shapiro S.H. Scientific challenges in the application of randomized trials. JAMA. 252:1984;2739-2745.
14. Strom B.L., Melmon K.L. The use of pharmacoepidemiology to study beneficial drug effects. Strom B.L. Pharmacoepidemiology. 2:1994;John & Sons Ltd, Chichester.
15. Strom B.L., Melmon K.L., Miettinen O.S. Postmarketing studies of drug efficacy. Why? Am J Med. 78:1985;475-480.
16. Miettinen O.S. The need for randomization in the study of intended effects. Stat Med. 2:1983;267-271.
17. Joseph K.S. The evolution of clinical practice and time trends in drug effects. J Clin Epidemiol. 47:1994;593-598.
18. Wen S.W., Hernandez R., Naylor C.D. Pitfalls in nonrandomized outcomes studies. The case of incidental appendectomy with open cholecystectomy JAMA. 274:1995;1687-1691.
19. Concato J., Horwitz R.I., Feinstein A.R., Elmore J.G., Schiff S.F. Problems of comorbidity in mortality after prostatectomy. JAMA. 267:1992;1077-1082.
20. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative database. J Clin Epidemiol. 45:1992;613-619.
21. Charlson M.E., Pompei P., Ales K.L.et al. A new method of classifying prognostic comorbidity in longitudinal studies. Development and validation J Chron Dis. 40:1987;373-383.
22. Iezzoni L.I. Risk and outcomes. Iessoni L.I. Risk Adjustment for Measuring Health Outcomes. 1994;Health Administration Press, Ann Arbor, MI.
23. Daley J., Shwartz M. Developing risk-adjustment methods. Iezzoni L.I. Risk Adjustment for Measuring Health Outcomes. 1994;Health Administration Press, Ann Arbor, MI.
24. Miettinen O.S. Efficacy of therapeutic practice. Will epidemiology provide the answers? Melmon K.L. Drug Therapeutics. Concepts for Physicians:1981;Elsevier, New York.
25. Strom B.L., Miettinen O.S., Melmon K.L. Postmarketing studies of drug efficacy. How? Am J Med. 77:1984;703-708.
26. Roos N.P., Wennberg J.E., Mcpherson K. Using diagnosis-related groups for studying variations in hospital admissions. Health Care Financing Review. 9:1988;53-62.
27. Wennberg J.E., Gittelsohn A. Small area variations in health care delivery. Science. 182:1973;1102-1107.
28. Wennberg J.E. Mark Blumberg's thesis that morbidity adjusters are needed to interpret small area variations. Med Care. 25:1987;354-359.
29. Wennberg J.E., Barnes B.A., Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med. 16:1982;811-824.
30. Leape L.L. Unnecessary surgery. Ann Rev Pub Health. 13:1992;363-383.
31. Naylor C.D., Anderson G.M., Goel V. Patterns of Health Care in Ontario. 1994;CMA Publications Group, Ottawa.
32. Wen SW, Liu S, Kramer MS, Joseph KS, Levitt C, Marcoux S, Liston RL. The impact of prenatal glucose screening on the diagnosis and consequences of gestational diabetes (Submitted for publication).